These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway. Lapalombella R; Andritsos L; Liu Q; May SE; Browning R; Pham LV; Blum KA; Blum W; Ramanunni A; Raymond CA; Smith LL; Lehman A; Mo X; Jarjoura D; Chen CS; Ford R; Rader C; Muthusamy N; Johnson AJ; Byrd JC Blood; 2010 Apr; 115(13):2619-29. PubMed ID: 19965642 [TBL] [Abstract][Full Text] [Related]
10. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells. Furman RR; Asgary Z; Mascarenhas JO; Liou HC; Schattner EJ J Immunol; 2000 Feb; 164(4):2200-6. PubMed ID: 10657675 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells. Laytragoon-Lewin N; Duhony E; Bai XF; Mellstedt H Eur J Haematol; 1998 Oct; 61(4):266-71. PubMed ID: 9820634 [TBL] [Abstract][Full Text] [Related]
12. Intratumoral delivery of CD154 homolog (Ad-ISF35) induces tumor regression: analysis of vector biodistribution, persistence and gene expression. Melo-Cardenas J; Urquiza M; Kipps TJ; Castro JE Cancer Gene Ther; 2012 May; 19(5):336-44. PubMed ID: 22402624 [TBL] [Abstract][Full Text] [Related]
13. CD40 ligand in CLL pathogenesis and therapy. Schattner EJ Leuk Lymphoma; 2000 May; 37(5-6):461-72. PubMed ID: 11042507 [TBL] [Abstract][Full Text] [Related]
14. Decreased sensitivity of 17p-deleted chronic lymphocytic leukemia cells to a small molecule BCL-2 antagonist ABT-737. Kojima K; Duvvuri S; Ruvolo V; Samaniego F; Younes A; Andreeff M Cancer; 2012 Feb; 118(4):1023-31. PubMed ID: 21761401 [TBL] [Abstract][Full Text] [Related]
15. Rapid and efficient nonviral gene delivery of CD154 to primary chronic lymphocytic leukemia cells. Li LH; Biagi E; Allen C; Shivakumar R; Weiss JM; Feller S; Yvon E; Fratantoni JC; Liu LN Cancer Gene Ther; 2006 Feb; 13(2):215-24. PubMed ID: 16082377 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-15 as a potential costimulatory cytokine in CD154 gene therapy of chronic lymphocytic leukemia. Anether G; Marschitz I; Tinhofer I; Greil R Blood; 2002 Jan; 99(2):722-3. PubMed ID: 11799965 [No Abstract] [Full Text] [Related]
17. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells. Decker T; Schneller F; Sparwasser T; Tretter T; Lipford GB; Wagner H; Peschel C Blood; 2000 Feb; 95(3):999-1006. PubMed ID: 10648415 [TBL] [Abstract][Full Text] [Related]
18. CD40 activation does not protect chronic lymphocytic leukemia B cells from apoptosis induced by cytotoxic T lymphocytes. Chu P; Wierda WG; Kipps TJ Blood; 2000 Jun; 95(12):3853-8. PubMed ID: 10845920 [TBL] [Abstract][Full Text] [Related]
19. Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes. Takahashi S; Rousseau RF; Yotnda P; Mei Z; Dotti G; Rill D; Hurwitz R; Marini F; Andreeff M; Brenner MK Hum Gene Ther; 2001 Apr; 12(6):659-70. PubMed ID: 11426465 [TBL] [Abstract][Full Text] [Related]
20. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies. Wang D; Freeman GJ; Levine H; Ritz J; Robertson MJ Br J Haematol; 1997 May; 97(2):409-17. PubMed ID: 9163608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]